The heads of several committees of the US House of Representatives have called on President Donald Trump to explain the decision to transfer artificial lung ventilation devices to Moscow during the COVID-19 pandemic.
The chairmen of several committees of the House of Representatives of the US Congress are calling on President Donald Trump to explain the decision to send several hundred artificial ventilation devices (ventilators) to Russia. These devices are “essential here to fight the crisis caused by the SARS-CoV-2 coronavirus and save the lives of Americans,” the letter to the head of the White House emphasizes.
The document was signed by, among others, Democrats Carolyn Maloney (oversight Committee), Eliot Engel (foreign Affairs Committee), and Nita Lowey (appropriations Committee). They require the President to tell Congress by June 4 exactly how his administration is evaluating the need for medical equipment supplies to other countries and their funding.
Ventilator for Russia for 5.6 million dollars
“It seems that you may be giving or selling these devices to other countries as gifts or services, for your own political or personal interests, without a meaningful strategic justification,” the letter notes. The Trump administration a few days earlier notified Congress that the supply of ventilators and related equipment in the Russian Federation would cost American taxpayers $ 5.6 million, the document says. According to congressmen, it is unacceptable to use American money to purchase and supply these devices abroad as a “political service.”
The authors of the letter do not believe that the United States is in a position that does not allow the transfer of crucial medical equipment to States that need them, the document emphasizes.
On May 20, the US National Security Council announced the delivery of ventilators to Moscow as humanitarian aid. They “will save lives in the most affected city in Russia,” the report said. Later, a representative of the US State Department told The Hill that another 150 devices of the California manufacturer would be transferred to the Pirogov National medical and surgical center in Moscow.